Hermine I. Brunner, MD, MSc, MBA

Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States

Dr. Brunner is a Professor of Pediatrics at the University of Cincinnati. She directs the Division of Rheumatology at Cincinnati Children's Hospital. As Scientific Director of the PRCSG she is designing and conducting clinical trials. Her personal research is in kidney and brain biomarkers for use in children with lupus.

Disclosure information not submitted.

Presentation(s):

• Round Table Discussions: Developing a Mentoring Program

  Friday, November 11, 2022
  4:10 PM – 5:00 PM Eastern Time

• Round Table Topic Report Outs and Closing Remarks

  Friday, November 11, 2022
  5:00 PM – 5:30 PM Eastern Time

• 523: CH Pediatrics: Office Hours: Pediatric Rheumatology Collaborative Study Group (PRCSG) and Clinical Trials

  Saturday, November 12, 2022
  1:00 PM – 1:45 PM Eastern Time

• 528: CH Leadership: Industry Relationships: Opportunities and Challenges and Q&A

  Saturday, November 12, 2022
  1:00 PM – 2:00 PM Eastern Time

• 0362: The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Renal Responses in Lupus Nephritis

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• Cognitive Impairment in Childhood-Onset SLE

  Saturday, November 12, 2022
  5:20 PM – 5:35 PM Eastern Time

• 2209: Efficacy of Secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis Subtypes of Juvenile Idiopathic Arthritis: Results from a Randomized, Phase 3 Study

  Monday, November 14, 2022
  3:00 PM – 3:10 PM Eastern Time

• 2212: Long-term Efficacy and Safety of Subcutaneous Tocilizumab in Patients with Polyarticular or Systemic Juvenile Idiopathic Arthritis – an Extension Study of 2 Phase 1b Clinical Trials

  Monday, November 14, 2022
  3:45 PM – 3:55 PM Eastern Time